Finding safe inhibitors of phosphodiesterase 4, the enzyme that breaks down cAMP, has been a longstanding goal in pharmaceutical development. Burgin et al. use crystal structure data to develop allosteric inhibitors that lack the emetic side effects of existing inhibitors in animals.
- Alex B Burgin
- Olafur T Magnusson
- Mark E Gurney
